April 6, 2026 – Thermo Fisher Scientific Inc. introduced the worldwide launch of the Gibco™ CTS™ Compleo™ Fill and End System, an automatic, functionally closed resolution designed to streamline formulation and filling in cell remedy manufacturing. As a result of cell therapies usually begin with patient-derived cells, manufacturing workflows should account for variability in cell quantity, focus, and viability. As extra therapies transfer towards commercialization, producers are looking for to cut back handbook intervention and enhance operational effectivity whereas sustaining strict necessities for sterility, dose accuracy and product consistency.

Formulation and filling are historically carried out utilizing handbook strategies that require cautious dealing with of fragile cells in small volumes, which introduces variability and threat of contamination.

The CTS Compleo system offers a compact, automated, functionally closed formulation and filling resolution, lowering handbook intervention and supporting constant efficiency from batch to batch.

Proceed studying